These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15053118)

  • 21. Who is chasing whom? A call for a more integrated approach to reduce the load of micro-pollutants in the environment.
    Schirmer K; Schirmer M
    Water Sci Technol; 2008; 57(1):145-50. PubMed ID: 18192752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discharge of pharmaceutical products (PPs) through a conventional biological sewage treatment plant: MECs vs PECs?
    Coetsier CM; Spinelli S; Lin L; Roig B; Touraud E
    Environ Int; 2009 Jul; 35(5):787-92. PubMed ID: 19201471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and evaluation of computer models for predicting environmental concentrations of pharmaceuticals and veterinary products in the Nordic environment.
    Wajsman D; Rudén C
    J Expo Sci Environ Epidemiol; 2006 Jan; 16(1):85-97. PubMed ID: 16030525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Do pharmaceutical waste and drug residue pose a risk to public health?].
    Haguenoer JM
    Sante Publique; 2010; 22(3):325-42. PubMed ID: 20858332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The treatment of hospital wastewater: an appraisal.
    Pauwels B; Verstraete W
    J Water Health; 2006 Dec; 4(4):405-16. PubMed ID: 17176811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Initial ecological risk assessment of eight selected human pharmaceuticals in Japan.
    Yamamoto H; Nakamura Y; Nakamura Y; Kitani C; Imari T; Sekizawa J; Takao Y; Yamashita N; Hirai N; Oda S; Tatarazako N
    Environ Sci; 2007; 14(4):177-93. PubMed ID: 17762841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxic risk of surface water pollution--six years of experience.
    Soldán P
    Environ Int; 2003 Mar; 28(8):677-82. PubMed ID: 12605913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmaceuticals in the environment].
    Bellante De Martiis G; Bellante L; Chiavola A; D'Aprile L; Sbaffoni S
    Ann Ig; 2004; 16(1-2):291-306. PubMed ID: 15554536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceutical and personal care products in tile drainage following land application of municipal biosolids.
    Lapen DR; Topp E; Metcalfe CD; Li H; Edwards M; Gottschall N; Bolton P; Curnoe W; Payne M; Beck A
    Sci Total Environ; 2008 Jul; 399(1-3):50-65. PubMed ID: 18455753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistence of pharmaceuticals and other organic compounds in chlorinated drinking water as a function of time.
    Gibs J; Stackelberg PE; Furlong ET; Meyer M; Zaugg SD; Lippincott RL
    Sci Total Environ; 2007 Feb; 373(1):240-9. PubMed ID: 17188338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of regulatory method estimated drinking water exposure concentrations with monitoring results from surface drinking water supplies.
    Jackson S; Hendley P; Jones R; Poletika N; Russell M
    J Agric Food Chem; 2005 Nov; 53(22):8840-7. PubMed ID: 16248594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA.
    Yu CP; Chu KH
    Chemosphere; 2009 Jun; 75(10):1281-6. PubMed ID: 19395062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceuticals and other organic chemicals in selected north-central and northwestern Arkansas streams.
    Haggard BE; Galloway JM; Green WR; Meyer MT
    J Environ Qual; 2006; 35(4):1078-87. PubMed ID: 16738393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent.
    Matamoros V; García J; Bayona JM
    Water Res; 2008 Feb; 42(3):653-60. PubMed ID: 17826819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the environmental impact of artificial effluent lagoon in Jiayuguan City of China.
    Pei YS; Luan ZK; Barber C; Williamson D
    J Environ Sci (China); 2003 Jul; 15(4):525-30. PubMed ID: 12974316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human health risk assessment from the presence of human pharmaceuticals in the aquatic environment.
    Cunningham VL; Binks SP; Olson MJ
    Regul Toxicol Pharmacol; 2009 Feb; 53(1):39-45. PubMed ID: 19013494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecules used for therapeutic or diagnostic purposes are micro water polluants].
    Levi Y
    Ann Pharm Fr; 2003 Nov; 61(6):365-72. PubMed ID: 14639186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceuticals in on-site sewage effluent and ground water, Western Montana.
    Godfrey E; Woessner WW; Benotti MJ
    Ground Water; 2007; 45(3):263-71. PubMed ID: 17470115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals in the aquatic environment--a comparison of risk assessment strategies.
    Bound JP; Voulvoulis N
    Chemosphere; 2004 Sep; 56(11):1143-55. PubMed ID: 15276728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.